{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:52:28Z","timestamp":1782172348223,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030610","name":"Emory University Department of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.cmi.2024.11.031","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T07:42:10Z","timestamp":1732347730000},"page":"575-581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Establishing piperacillin\u2013tazobactam susceptibility in ceftriaxone non-susceptible Enterobacterales: comparing disk diffusion, Etest, and VITEK 2 automated minimal inhibitory concentration measurements vs. broth microdilution"],"prefix":"10.1016","volume":"31","author":[{"given":"Zahra N.","family":"Sohani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Lieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reggie","family":"Bamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mical","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna","family":"Yahav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily G.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lawandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2024.11.031_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.031_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13756-018-0346-9","article-title":"A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States","volume":"7","author":"Livorsi","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.cmi.2024.11.031_bib3","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/677157","article-title":"Rising rates of carbapenem-resistant Enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States","volume":"35","author":"Thaden","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2024.11.031_bib4","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/cid\/ciab415","article-title":"Risk factors associated with carbapenemase-producing carbapenem-resistant Enterobacteriaceae positive cultures in a cohort of US veterans","volume":"73","author":"Wilson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.031_bib5","first-page":"15","article-title":"Carbapenem resistance: overview of the problem and future perspectives","volume":"3","author":"Meletis","year":"2016","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.031_bib6","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace","volume":"215","author":"Logan","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.031_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.33393\/dti.2020.2170","article-title":"Prevalence of multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing gram-negative bacilli: a meta-analysis report in Ethiopia","volume":"14","author":"Abayneh","year":"2020","journal-title":"Drug Target Insights"},{"key":"10.1016\/j.cmi.2024.11.031_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13756-023-01263-7","article-title":"Carriage of ESBL-producing Klebsiella pneumoniae and Escherichia coli among children in rural Ghana: a cross-sectional study","volume":"12","author":"Akenten","year":"2023","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.cmi.2024.11.031_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tmaid.2017.01.003","article-title":"Fluoroquinolone antibiotic users select fluoroquinolone-resistant ESBL-producing Enterobacteriaceae (ESBL-PE)\u2014data of a prospective traveller study","volume":"16","author":"Kantele","year":"2017","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.031_bib10","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1128\/AAC.00155-06","article-title":"Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline","volume":"50","author":"Morosini","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2024.11.031_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1469-0691.2007.01850.x","article-title":"Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe","volume":"14","author":"Cant\u00f3n","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.11.031_bib12","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.2018.12163","article-title":"Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial","volume":"320","author":"Harris","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2024.11.031_bib13","doi-asserted-by":"crossref","first-page":"e3842","DOI":"10.1093\/cid\/ciaa1479","article-title":"Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin\/tazobactam or meropenem from the MERINO study","volume":"73","author":"Henderson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.031_bib14","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","year":"2018"},{"key":"10.1016\/j.cmi.2024.11.031_bib15","series-title":"Performance standards for antimicrobial disk susceptibility tests; approved standard-twelfth edition. M02-A12","year":"2015"},{"key":"10.1016\/j.cmi.2024.11.031_bib16","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2024"},{"key":"10.1016\/j.cmi.2024.11.031_bib17","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1128\/AAC.01338-09","article-title":"High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada","volume":"54","author":"Peirano","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2024.11.031_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkab269","article-title":"ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007\u201318","volume":"76","author":"Karlowsky","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2024.11.031_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040210","article-title":"Piperacillin\u2013tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)","volume":"11","author":"Bitterman","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2024.11.031_bib20","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1128\/AAC.00521-12","article-title":"Population pharmacokinetics of extended-infusion piperacillin-tazobactam in hospitalized patients with nosocomial infections","volume":"56","author":"Felton","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24005627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24005627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T19:20:10Z","timestamp":1746472810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X24005627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1198743X24005627"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2024.11.031","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishing piperacillin\u2013tazobactam susceptibility in ceftriaxone non-susceptible Enterobacterales: comparing disk diffusion, Etest, and VITEK 2 automated minimal inhibitory concentration measurements vs. broth microdilution","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2024.11.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}